Effect of Controlled Release/Extended Release Metoprolol on Carotid Intima-Media Thickness in Patients With Hypercholesterolemia
Author(s) -
Olov Wiklund,
Johannes Hulthe,
John Wikstrand,
Caroline Schmidt,
SvenOlof Olofsson,
Göran Bondjers
Publication year - 2002
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/hs0202.102332
Subject(s) - medicine , metoprolol , placebo , randomization , cardiology , concomitant , intima media thickness , randomized controlled trial , aspirin , common carotid artery , stroke (engine) , cholesterol , beta blocker , gastroenterology , carotid arteries , alternative medicine , pathology , mechanical engineering , heart failure , engineering
Beta-adrenergic blockade has in several studies been shown to improve survival after myocardial infarction. In animal experiments beta-blockers have also shown an antiatherosclerotic effect. The aim of this study was to test the hypothesis that the beta-blocker metoprolol succinate controlled release/extended release (CR/XL), when given to patients with hypercholesterolemia on concomitant lipid-lowering therapy, provides an additional antiatherosclerotic effect to that provided by the statins, measured as carotid intima-media thickness (IMT).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom